Human Immunodeficiency Virus (HIV) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Human Immunodeficiency Virus (HIV) Tests Market Report Overview

The human immunodeficiency virus (HIV) tests market size was valued at $1.95 billion in 2023. The HIV test market will grow at a CAGR of more than 2% from 2023 to 2033. The Human Immunodeficiency Virus (HIV) has become one of the world’s most serious health issues affecting approximately 36.3 million people. In the first few weeks after attaining HIV, patients develop symptoms like fever, rash, sore throat, etc but as the infection progresses. they become nonimmune to a greater extent leading to a decrease in CD4 count and undergo symptoms like swollen lymph nodes, weight loss, fever, diarrhoea, and cough. It may result in the development of Immunodeficiency syndrome or severe illnesses such as cryptococcal meningitis, tuberculosis, severe bacterial infections, and cancers such as lymphomas and Kaposi’s sarcoma if left untreated for a long time.

HIV Tests Market Outlook 2023-2033 ($ Billion)

HIV Tests Market Outlook 2023-2033 ($ Billion)

Buy the Full Report for More Insights on the HIV Tests Market Forecast, Download a Free Sample Report

The HIV tests market research report explains the market behavior, which will help identify quantitative market trends within in vitro diagnostics therapeutic areas. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing in-licensing and out-licensing strategies. The HIV tests market model also discusses the detailed impact of COVID-19 on the HIV tests market for 2020 and beyond.

Market Size (2023) $1.95 billion
CAGR (2023-2033) >2%
Historic Period 2015-2023
Forecast Period 2023-2033
Key Segments ·        CD4 Count Tests

·        HIV Enzyme Immuno Assay/Enzyme-Linked Immunosorbent Assay (EIA/ELISA) Tests

·        HIV Nucleic Acid Amplification Tests (NAATs)

·        HIV Point of Care (POC) Tests

Key Regions
  • Asia-Pacific
  • Europe
  • Middle East and Africa
  • North America
  • South and Central America
Key Companies
  • Abbott Laboratories
  • Becton Dickinson and Co
  • Danaher Corp
  • Bio-Rad Laboratories Inc
  • F. Hoffmann-La Roche Ltd
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

HIV Tests Market Dynamics

HIV is an ongoing, global public health issue that remains a priority for most governments.  HIV tests are performed for two purposes including the screening and diagnosis and the monitoring of HIV-positive patients, particularly those undergoing antiretroviral therapy (ART). A rise in HIV incidence is predicted to lead to a higher number of suspected infection cases being tested as well as improved disease awareness and continuation of strong screening initiatives. Additionally, the prevalence of the disease is also predicted to increase, and this is expected to bolster sales of HIV NAATs used to measure the viral load, as well as CD4 count tests.

The incidence of HIV is expected to increase in many countries during the forecast period. In each country, HIV test sales are influenced by a variety of factors including fluctuations in disease incidence, rising HIV prevalence, the number of pregnant women, sperm donations, blood donations, and source plasma donations.

Buy the Full Report for Additional Information on the HIV Tests Market Dynamics, Download a Free Sample Report

HIV Tests Market Segments

The key segments in the HIV tests market are CD4 Count Tests, HIV Enzyme Immuno Assay/Enzyme-Linked Immunosorbent Assay (EIA/ELISA) Tests, HIV Nucleic Acid Amplification Tests (NAATs), and HIV Point of Care (POC) Tests. In 2023, the HIV Enzyme Immuno Assay/Enzyme-Linked Immunosorbent Assay (EIA/ELISA) Tests segment dominated the HIV test market share. The segment will continue to retain its dominance during the projected period.

HIV Tests Market Analysis by Segments, 2023 (%)

HIV Tests Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Insights into the HIV Tests Market Segments, Download a Free Sample Report

HIV Tests Market Segmentation by Regions

The key regions in the HIV tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, North America led the global market with the US being the largest contributor to HIV tests sales. A large proportion of tests are performed on pregnant women and donors of human cells, tissues, and cellular and tissue-based products thereby driving the market growth. The US and Canadian HIV test markets will be driven by an increase in source plasma and whole blood donations, respectively. The number of pregnant women in these two countries is also expected to increase, further augmenting the HIV test market.

HIV Tests Market Analysis by Regions, 2023 (%)

HIV Tests Market Analysis by Regions, 2023 (%)

Buy the Full Report for More Regional Insights in the HIV Tests Market, Download A Free Sample Report

HIV tests Market – Competitive Landscape

The key companies in the HIV tests market are Abbott Laboratories, Becton Dickinson and Co, Danaher Corp, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd among others. In 2023, F. Hoffmann-La Roche Ltd accounted for the highest HIV tests market share and value.

HIV Tests Market Analysis by Companies, 2023 (%)

HIV Tests Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Company-Wise Insights into the HIV Tests Market, Download a Free Sample Report

Segments Covered in this Report.

HIV Tests Segment Outlook ($ Million, 2015-2033)

  • CD4 Count Tests
  • HIV Enzyme Immuno Assay/Enzyme-Linked Immunosorbent Assay (EIA/ELISA) Tests
  • HIV Nucleic Acid Amplification Tests (NAATs)
  • HIV Point of Care (POC) Tests

HIV Tests Regional Outlook ($ Million, 2015-2033)

  • Asia-Pacific
  • Europe
  • Middle East and Africa
  • North America
  • South and Central America

Key Inclusions of the market model are –

Currently marketed HIV tests market and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total HIV tests market revenue by segment and market outlooks from 2015-2033.
  • Market-level data on units, average selling prices, and market values.

Global, Regional, and Country level market specific insights:

  • Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for the HIV tests market.
  • Competitive dynamics insights and trends provided for the HIV tests market.

Get an in-depth understanding of consumer behavior through the market access segment and the overview of the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.

  • Country-specific overview of the healthcare system.
  • Country-specific reimbursement policies.
  • Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, the report helps determine market trends through real-world data sources including government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Becton Dickinson and Co, Danaher Corp, Bio-Rad Laboratories Inc, Hologic Inc, OraSure Technologies Inc, QuidelOrtho Corp, Oswaldo Cruz Foundation, Grifols SA, F. Hoffmann-La Roche Ltd, Siemens AG, Qiagen NV, Trinity Biotech Plc, and others.

Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.


This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. The model will benefit the following stakeholders:

  • CMO executives must have a deep understanding of the HIV tests marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives must understand crucial components of the supply base to make decisions about supplier selection and management.
  • Private equity investors who need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

  • Understand the impact of COVID-19 on HIV tests.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving HIV tests.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the HIV tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific HIV tests market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Frequently asked questions

Human Immunodeficiency Virus (HIV) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 standard reports
Currency USD

Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Human Immunodeficiency Virus (HIV) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Human Immunodeficiency Virus (HIV) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 in real time.

  • Access a live Human Immunodeficiency Virus (HIV) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.